Join the Prostate Cancer group to help and get support from people like you.
Prostate Cancer News (Page 5)
Related terms: Cancer, Prostate, Carcinoma of Prostate
Long-Term Complications After Prostate Cancer Treatment Not Uncommon
FRIDAY, Nov. 8, 2024 – Prostate cancer (PCA) treatment is associated with increased rates of complications in the 12 years after treatment, according to a study published online Nov. 7 in JAMA...
AI Aids Risk Prediction Classification for Prostate Cancer
WEDNESDAY, Nov. 6, 2024 – Artificial intelligence (AI)-based risk classification improves prognostication with localized prostate cancer, according to a study published online Oct. 24 in JCO...
22 Pesticides Linked to Prostate Cancer Risk
TUESDAY, Nov. 5, 2024 – Exposure to any one of 22 pesticides may bring heightened odds of developing prostate cancer, a new analysis suggests. The study was conducted over decades because prostate...
Certain Pesticides Tied to Increased Prostate Cancer Incidence, Mortality
MONDAY, Nov. 4, 2024 – Some pesticides are associated with increased prostate cancer incidence and mortality, according to a study published online Nov. 4 in Cancer. Simon John Christoph Soerensen,...
How AI Might Help Men Fighting Prostate Cancer
TUESDAY, Oct. 29, 2024 – Artificial intelligence might be able to help doctors detect the prostate cancers most likely to be life-threatening to men, a new study suggests. An AI program successfully...
Higher Heathy Eating Index Score Beneficial in Prostate Cancer
THURSDAY, Oct. 24, 2024 – Higher adherence to American dietary guideline recommendations may be associated with a lower risk for grade reclassification in men diagnosed with grade group 1 (GG1)...
Healthy Eating May Keep 'Low Grade' Prostate Cancers in Check
MONDAY, Oct. 21, 2024 – A healthy diet can help keep prostate cancer in check, a new study finds. The better a man eats, the less likely his low-grade prostate cancer will progress to a more...
Stereotactic Body Radiotherapy Viable Alternative for Localized Prostate Cancer
THURSDAY, Oct. 17, 2024 – Stereotactic body radiotherapy (SBRT) is noninferior to conventional or moderately fractionated radiotherapy for localized prostate cancer (PC), according to a study...
Time to Testosterone Recovery Varies With ADT Duration
THURSDAY, Oct. 10, 2024 – For men receiving androgen deprivation therapy (ADT) for prostate cancer, time to testosterone recovery (TR) varies with ADT duration, according to a study published online...
Blood Test Can Help Predict Survival From Advanced Prostate Cancer
MONDAY, Oct. 7, 2024 – A simple blood test may help doctors decide the best way to treat a man with advanced prostate cancer. A phase 3 clinical trial has shown that circulating tumor cell (CTC)...
ASTRO: Intensity-Modulated RT, Proton Beam Therapy Have Similar Outcomes in Prostate Cancer
FRIDAY, Oct. 4, 2024 – Intensity-modulated radiation therapy (IMRT) and proton beam therapy (PBT) offer similar outcomes for patients with localized prostate cancer, according to a study presented...
Cancer Incidence Rates in 2021 Indicate Return to Prepandemic Levels
MONDAY, Sept. 30, 2024 – The overall incidence rates for all cancer sites and specific cancer sites returned to prepandemic levels in 2021, according to a study published online Sept. 24 in the...
No Infections Seen After Transperineal Biopsy for Prostate Cancer
MONDAY, Sept. 30, 2024 – For patients with suspicion for prostate cancer, transperineal biopsy has similar cancer detection rates as transrectal biopsy but a significantly lower risk for infection,...
Pfizer and Astellas' Xtandi Approved by U.S. FDA in Earlier Prostate Cancer Treatment Setting
TOKYO and NEW YORK, Nov. 16, 2023 /PRNewswire/ – Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Pfizer Inc. (NYSE: PFE) today announced that the companies...
FDA Approves Akeega (niraparib and abiraterone acetate) for the Treatment of Patients with BRCA-Positive Metastatic Castration-Resistant Prostate Cancer
HORSHAM, Pa., August 11, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food & Drug Administration (FDA) has approved Akeega™ (niraparib and abi...
Further information
Related condition support groups
Related drug support groups
Lupron, Lupron Depot, estradiol, Premarin, Estrace, Xtandi, docetaxel, Zytiga